Teva Pharmaceutical (Germany) Investor Sentiment

TEV Stock  EUR 21.00  0.20  0.94%   
Roughly 62% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Teva Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Teva daily returns and investor perception about the current price of Teva Pharmaceutical Industries as well as its diversification or hedging effects on your existing portfolios.
  
over two weeks ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Purchased by Two Sigma Advisers LP - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Okabena Investment Services Inc. Purchases New Holdings in Teva Pharmaceutical Industries Limited - ...
Google News at Macroaxis
over a month ago at news.google.com         
TEVA EPS without NRI 2.78 - GuruFocus.com
Google News at Macroaxis
over a month ago at news.google.com         
How the price action is used to our Advantage - Stock Traders Daily
Google News at Macroaxis
over a month ago at news.google.com         
Teva Pharmaceutical Industries Q3 2024 Earnings Call Transcript - The Motley Fool
Google News at Macroaxis
over a month ago at news.google.com         
TEVA - Teva Pharmaceutical Industries Limited American Depositary Shares Latest Stock News Market Up...
Google News at Macroaxis
over two months ago at news.google.com         
Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited Right Now - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on Novembe...
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceutical Industries shareholders have earned a 21 percent CAGR over the last five years -...
Google News at Macroaxis
over three months ago at news.google.com         
Tri Locum Partners LP Grows Stock Position in Teva Pharmaceutical Industries Limited - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Sold by Rubric Capital Management LP - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceutical Industries Limited is favoured by institutional owners who hold 68 percent of th...
Google News at Macroaxis
over three months ago at news.google.com         
TEVA stock soars to 52-week high, reaches 18.89 - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
UBS raises Teva Pharma stock price target on duvakitug prospects - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Technical Data - Stock Traders Daily
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites